334 related articles for article (PubMed ID: 32084065)
21. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
22. Melatonin therapy to improve nocturnal sleep in critically ill patients: encouraging results from a small randomised controlled trial.
Bourne RS; Mills GH; Minelli C
Crit Care; 2008; 12(2):R52. PubMed ID: 18423009
[TBL] [Abstract][Full Text] [Related]
23. Sleep in the intensive care unit.
Lee EY; Wilcox ME
Curr Opin Pulm Med; 2022 Nov; 28(6):515-521. PubMed ID: 36101905
[TBL] [Abstract][Full Text] [Related]
24. Prescription Drugs Used in Insomnia.
Dujardin S; Pijpers A; Pevernagie D
Sleep Med Clin; 2020 Jun; 15(2):133-145. PubMed ID: 32386689
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic Considerations Surrounding Sedation, Delirium, and Sleep in Critically Ill Adults: A Narrative Review.
Smithburger PL; Patel MK
J Pharm Pract; 2019 Jun; 32(3):271-291. PubMed ID: 30955461
[TBL] [Abstract][Full Text] [Related]
26. Sleep and delirium in the intensive care unit.
Mistraletti G; Carloni E; Cigada M; Zambrelli E; Taverna M; Sabbatini G; Umbrello M; Elia G; Destrebecq AL; Iapichino G
Minerva Anestesiol; 2008 Jun; 74(6):329-33. PubMed ID: 18500209
[TBL] [Abstract][Full Text] [Related]
27. Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled Trial.
Skrobik Y; Duprey MS; Hill NS; Devlin JW
Am J Respir Crit Care Med; 2018 May; 197(9):1147-1156. PubMed ID: 29498534
[TBL] [Abstract][Full Text] [Related]
28. Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial.
Nishikimi M; Numaguchi A; Takahashi K; Miyagawa Y; Matsui K; Higashi M; Makishi G; Matsui S; Matsuda N
Crit Care Med; 2018 Jul; 46(7):1099-1105. PubMed ID: 29595562
[TBL] [Abstract][Full Text] [Related]
29. Ramelteon is Not Associated With Improved Outcomes Among Critically Ill Delirious Patients: A Single-Center Retrospective Cohort Study.
Thom R; Bui M; Rosner B; Teslyar P; Levy-Carrick N; Wolfe D; Klompas M
Psychosomatics; 2019; 60(3):289-297. PubMed ID: 30193784
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: a review of data from prospective, randomised studies.
Devlin JW; Al-Qadhee NS; Skrobik Y
Best Pract Res Clin Anaesthesiol; 2012 Sep; 26(3):289-309. PubMed ID: 23040282
[TBL] [Abstract][Full Text] [Related]
31. [Usefulness of Suvorexant for Complicated Delirium in Cancer Patients Who Experience Sleep Disturbance during Hospitalization].
Kessoku T; Kusakabe A; Matsuura T; Honda Y; Yoshimi A; Goto A; Yoshida H; Sukegawa A; Hata C; Saito Y; Miyashita Y; Yashiro R; Komori T; Arai S; Nakajima A; Ichikawa Y
Gan To Kagaku Ryoho; 2018 Mar; 45(Suppl 1):92-94. PubMed ID: 29650886
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Melatonin for the Prevention of Intensive Care Unit Delirium.
Baumgartner L; Lam K; Lai J; Barnett M; Thompson A; Gross K; Morris A
Pharmacotherapy; 2019 Mar; 39(3):280-287. PubMed ID: 30663785
[TBL] [Abstract][Full Text] [Related]
33. Suvorexant with or without ramelteon to prevent delirium: a systematic review and meta-analysis.
Tian Y; Qin Z; Han Y
Psychogeriatrics; 2022 Mar; 22(2):259-268. PubMed ID: 34881812
[TBL] [Abstract][Full Text] [Related]
34. Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS): protocol for a randomised, double-blind, parallel-arm, placebo-controlled trial.
Shelton KT; Qu J; Bilotta F; Brown EN; Cudemus G; D'Alessandro DA; Deng H; DiBiasio A; Gitlin JA; Hahm EY; Hobbs LE; Houle TT; Ibala R; Loggia ML; Pavone KJ; Shaefi S; Tolis G; Westover MB; Akeju O
BMJ Open; 2018 Apr; 8(4):e020316. PubMed ID: 29678977
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic Sleep Aids in the Intensive Care Unit: A Systematic Review.
Singh G; Nguyen C; Kuschner W
J Intensive Care Med; 2024 Jun; ():8850666241255345. PubMed ID: 38881385
[No Abstract] [Full Text] [Related]
36. Non-24-hour sleep-wake disorder successfully treated with the combination of ramelteon and suvorexant in a case of autism spectrum disorder.
Iwata M; Kaneko K
Neuropsychopharmacol Rep; 2020 Dec; 40(4):383-387. PubMed ID: 32990413
[TBL] [Abstract][Full Text] [Related]
37. Factors Associated With Delirium in Surgical Intensive Care Unit Patients Treated With Supplemental Melatonin: A Case-Cohort Study.
Cusimano JM; Welch S; Perez-Protto S; Lam S
Clin Neuropharmacol; 2019; 42(3):67-72. PubMed ID: 30920404
[TBL] [Abstract][Full Text] [Related]
38. Melatonin for delirium prevention in hospitalized patients: A systematic review and meta-analysis.
Khaing K; Nair BR
J Psychiatr Res; 2021 Jan; 133():181-190. PubMed ID: 33348252
[TBL] [Abstract][Full Text] [Related]
39. Melatonin: possible implications for the postoperative and critically ill patient.
Bourne RS; Mills GH
Intensive Care Med; 2006 Mar; 32(3):371-9. PubMed ID: 16477412
[TBL] [Abstract][Full Text] [Related]
40. Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia.
Yoshikawa F; Shigiyama F; Ando Y; Miyagi M; Uchino H; Hirose T; Kumashiro N
Diabetes Res Clin Pract; 2020 Nov; 169():108412. PubMed ID: 32911037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
